Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Cytochalasin D for Corneal Nanoparticle Uptake
2026-09-03
Cytochalasin D helps separate actin-dependent nanoparticle internalization from simple particle association in human corneal epithelial cell assays. This workflow combines controlled cytoskeletal perturbation with particle-size and surface-chemistry comparisons for more interpretable ocular drug-delivery data.
Influenza Hemagglutinin (HA) Peptide in Translation
2026-09-03
Translational biology depends on experimental systems that preserve mechanistic resolution while supporting reproducible protein analysis. This article connects the IDH1-R132H autopalmitoylation study with strategic HA-tag workflows, showing how a competitive elution reagent can strengthen construct validation, protein-interaction studies, and preclinical evidence chains.
Maternal IL-17A and Neonatal GBS Risk
2026-09-02
A prospective mother–newborn study in Morocco links reduced maternal IL-17A, IL-1β, and IL-4 responses among GBS-colonized women with invasive neonatal GBS disease. Its paired clinical and ex vivo design positions IL-17A as a promising risk-stratification biomarker while highlighting TLR1/2-responsive immune function as a relevant experimental endpoint.
Pol II Degradation and Transcription-Independent Cell Death
2026-09-02
The reference preprint separates the consequences of removing RNA polymerase II from those of simply suppressing transcription. Its central implication is that Pol II degradation can activate cell death through a mechanism that cannot be explained solely by loss of transcriptional output, prompting more careful experimental discrimination between polymerase depletion, transcriptional stress, and downstream death pathways.
2'3'-cGAMP: A Translational STING Control
2026-09-01
2'3'-cGAMP is more than a pathway activator: it is a mechanistic reference point for separating DNA sensing from STING execution. This thought-leadership guide connects its biochemical precision with experimental design, pathway inhibition, immunotherapy research, and translational decision-making.
Doxycycline hyclate in MMP/BBB research
2026-09-01
Doxycycline hyclate provides a practical way to interrogate MMP-linked barrier injury, neuronal apoptosis, and vascular inflammation across coordinated in vitro and in vivo workflows. Its solubility options, established MMP-2/MMP-9 study benchmark, and broader antiviral and antimalarial research utility make it more versatile than a single-endpoint inhibitor.
Atorvastatin and Ferroptosis in Hepatocellular Carcinoma
2026-08-31
Wang et al. integrated ferroptosis-related transcriptomics, clinical survival modeling, Connectivity Map screening, and experimental validation to develop a four-gene prognostic signature for hepatocellular carcinoma and identify Atorvastatin as a candidate therapeutic compound. The study supports a hypothesis-generating link between ferroptosis biology and Atorvastatin-mediated suppression of HCC growth and migration, while leaving clinical efficacy and detailed mechanism to be established.
C34 TLR4 Inhibitor: Applied Research Workflows
2026-08-31
C34 is a selective TLR4 inhibitor for separating receptor-driven inflammation from broader cellular stress. This guide translates its macrophage, enterocyte, intestinal-tissue, and microglia applications into practical workflows, controls, and troubleshooting decisions.
BRD4770 and the Translational Logic of G9a Biology
2026-08-30
BRD4770 offers translational researchers a practical way to interrogate G9a/EHMT2-dependent chromatin regulation. By reducing intracellular H3K9 methylation, the compound connects epigenetic mechanism with senescence and proliferation phenotypes in PANC-1 cells. This article places those findings alongside breast cancer evidence linking BRD4 and RAC1 inhibition to the c-MYC–G9a–FTH1 axis, while clearly separating pathway context from direct BRD4770 validation. It also provides a decision framework for pharmacodynamic assays, formulation, controls, and responsible interpretation.
EZ Cap™ Human PTEN mRNA (ψUTP) Workflow
2026-08-29
Build reproducible PTEN-restoration assays with Cap 1, pseudouridine-modified, polyadenylated mRNA. This workflow connects formulation, signaling readouts, and trastuzumab-resistance models while providing practical controls for delivery, innate responses, and variable expression.
ATG4B Links Energy Deficiency to AML DNA Repair Failure
2026-08-28
A 2025 Advanced Science study identifies nuclear translocation of ATG4B as a molecular link between energy deficiency, impaired PRMT1–MRE11 DNA repair, and acute myeloid leukemia progression. Its combination of mechanistic cell studies, leukemia models, and patient-derived xenografts suggests that ATG4B inhibition may reduce genomic instability and malignant expansion, although clinical translation remains unresolved.
Bleomycin Sulfate: From DNA Damage to STING Assays
2026-08-28
Bleomycin Sulfate is more than a fibrosis inducer or cytotoxic antibiotic: it can serve as a controlled injury input for testing macrophage-targeted STING interventions. This guide connects DNA strand-break biology with assay design, pulmonary fibrosis research, and translational decision-making.
AZ505: A Selective SMYD2 Inhibitor
2026-08-27
AZ505 is a substrate-competitive SMYD2 inhibitor that targets the peptide-binding groove of the lysine methyltransferase. Its reported biochemical potency, selectivity profile, and activity in cisplatin-associated renal fibrosis models make it a useful tool for epigenetic regulation research and cancer biology research.
ONX-0914 Workflows for Immunoproteasome Research
2026-08-27
ONX-0914 (PR-957) enables selective LMP7 inhibition for dissecting cytokine regulation, immune-cell activation, and disease-relevant proteasome activity. This practical workflow connects PBMC assays with arthritis, diabetes, and exploratory breast cancer studies while emphasizing dose control, matched controls, and interpretation limits.
Vardenafil HCl Trihydrate for PDE5 Research
2026-08-26
Vardenafil HCl Trihydrate supports a connected workflow from nanomolar PDE5 inhibition assays to cGMP-linked smooth muscle studies and proteoform-aware off-target analysis. Its strong PDE5 selectivity, water solubility, and compatibility with native membrane investigations make it useful for both routine pharmacology and mechanism-focused assay development.
8690 records 9/580 page Previous Next First page 上5页 678910 下5页 Last page